Skip to main content
Log in

Decreased half-life of insulin-like growth factor I in Rabson–Mendenhall syndrome

  • Published:
Journal of Inherited Metabolic Disease

Abstract

Rabson–Mendenhall syndrome is an autosomal recessive disorder of insulin signalling caused by mutations in the insulin receptor gene. Affected patients are insensitive to exogenous insulin. Insulin-like growth factor I (IGF-I), whose receptor is similar to the one for insulin and is not impaired in this condition, is not always effective in these patients. To understand the reason for this failure, IGF-I concentrations were measured in a patient after subcutaneous injection of 0.1 and 0.2 mg/kg of rhIGF-I. IGF-I concentrations increased only transiently because of the short half-life (1.3–3 h, compared to a normal range of 17–22 h). No correlation was found between IGF-I concentrations and glucose or insulin concentrations. The short half-life of IGF-I may contribute to treatment failure in patients with inherited insulin-resistant syndromes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  • Backeljauw PF, Alves C, Eidson M, Cleveland W, Underwood LE, Davenport ML (1994) Effect of intravenous IGF-I in two patients with leprechaunism. Pediatr Res 36: 749-754.

    Google Scholar 

  • Grahnen A, Kastrup K, Heinrich U, et al (1993) Pharmacokinetics of recombinant human insulin-like growth factor I given subcutaneously to healthy volunteers and to patients with growth hormone receptor deficiency. Acta Paediatr (Suppl) 82(supplement 391): 9-13.

    Google Scholar 

  • Kuzuya H, Matsuura N, Sakamoto M, et al (1993) Trial of IGF-I therapy for patients with extreme insulin resistance syndromes. Diabetes 42: 696-705.

    Google Scholar 

  • LeRoith D, Butler AA (1999) Insulin-like growth factors in pediatric health and disease. J Clin Endocrinol Metab 84: 4355-4361.

    Google Scholar 

  • Longo N, Singh R, Griffin LD, Langley SD, Parks JS, Elsas LJ (1994) Impaired growth in Rabson-Mendenhall syndrome: lack of effect of growth hormone and IGF-I. J Clin Endocrinol Metab 79: 799-805.

    Google Scholar 

  • Longo N, Wang Y, Pasquali M (1999) Progressive decline in insulin levels in Rabson-Mendenhall syndrome. J Clin Endocrinol Metab 84: 2623-2629.

    Google Scholar 

  • Nakae J, Kato M, Murashita M, Shinohara N, Tajima T, Fujieda K (1998) Long-term effect of recombinant human IGF-I on metabolic and growth control in a patient with leprechaunism. J Clin Endocrinol Metab 83: 542-549.

    Google Scholar 

  • Psiachou H, Mitton S, Alaghaband-Zadeh J, Hone J, Taylor SI, Sinclair L (1993) Leprechaunism and homozygous nonsense mutation in the insulin receptor gene. Lancet 342: 924.

    Google Scholar 

  • Quin JD, Fisher BM, Paterson KR, Inoue A, Beastall GH, MacCuish AC (1990) Acute response to recombinant IGF-I in a patient with Mendenhall's syndrome. N Engl J Med 323: 1425-1426.

    Google Scholar 

  • Schoenle EJ, Zenobi PD, Torresani T, Wender EA, Zachmann M, Froesch ER (1991) rhIGF-I reduces hyperglycaemia in patients with extreme insulin resistance. Diabetologia 34: 675-679.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Longo, N., Singh, R. & Elsas, L.J. Decreased half-life of insulin-like growth factor I in Rabson–Mendenhall syndrome. J Inherit Metab Dis 24, 546–550 (2001). https://doi.org/10.1023/A:1012411709972

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012411709972

Keywords

Navigation